Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Short-term Investments (2018 - 2020)

Updated

Emmaus Life Sciences (EMMA) reported Short-term Investments of $27.01 million for Q2 2020, down 17.9% from $32.89 million a year earlier and down 22.3% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Short-term Investments (2018 - 2020) Analysis & Trends

At the end of FY2019, Emmaus Life Sciences posted Short-term Investments of $27.93 million, down 43.4% from FY2018.

  • By year, Short-term Investments came in at $49.34 million in FY2018.
  • Year over year, Short-term Investments has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2020 came in at $34.77 million (Q1 2020), $27.93 million (Q4 2019) and $27.64 million (Q3 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 27.01 Mn
Mar 31, 2020 34.77 Mn
Dec 31, 2019 27.93 Mn
Sep 30, 2019 27.64 Mn
Jun 30, 2019 32.89 Mn
Mar 31, 2019 42.87 Mn
Dec 31, 2018 49.34 Mn
API Access

Emmaus Life Sciences Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=EMMA&period=max&api_key=YOUR_API_KEY